Tuberculosis Prevention and Treatment Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Prevention and Treatment Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Prevention and Treatment Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Prevention and Treatment Vaccine Overall Market Size
2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size: 2021 VS 2028
2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Tuberculosis Prevention and Treatment Vaccine Players in Global Market
3.2 Top Global Tuberculosis Prevention and Treatment Vaccine Companies Ranked by Revenue
3.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Companies
3.4 Global Tuberculosis Prevention and Treatment Vaccine Sales by Companies
3.5 Global Tuberculosis Prevention and Treatment Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tuberculosis Prevention and Treatment Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Prevention and Treatment Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Prevention and Treatment Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Prevention and Treatment Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Market Size Markets, 2021 & 2028
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
4.3.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
4.3.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Tuberculosis Prevention and Treatment Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Market Size, 2021 & 2028
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
5.3.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
5.3.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Tuberculosis Prevention and Treatment Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
6.3.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
6.3.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.4.3 US Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.4.4 Canada Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.4.5 Mexico Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.5.3 Germany Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.4 France Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.5 U.K. Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.6 Italy Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.7 Russia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.9 Benelux Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.6.3 China Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.4 Japan Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.5 South Korea Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.7 India Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.7.3 Brazil Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.7.4 Argentina Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.8.3 Turkey Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.4 Israel Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.6 UAE Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Corporate Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Japan BCG Lab Key News
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporate Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Serum Institute of India Key News
7.4 AJ Vaccines
7.4.1 AJ Vaccines Corporate Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 AJ Vaccines Key News
7.5 BioFarma
7.5.1 BioFarma Corporate Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 BioFarma Key News
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Corporate Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 GreenSignal Bio Pharma Key News
7.7 China National Biotec
7.7.1 China National Biotec Corporate Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 China National Biotec Key News
7.8 Biomed Lublin
7.8.1 Biomed Lublin Corporate Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Biomed Lublin Key News
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Corporate Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Taj Pharmaceuticals Key News
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Corporate Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Ataulpho de Paiva Key News
7.11 IVAC
7.11.1 IVAC Corporate Summary
7.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Business Overview
7.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 IVAC Key News
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Corporate Summary
7.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Queen Saovabha Mem. Inst Key News
7.13 Microgen
7.13.1 Microgen Corporate Summary
7.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Business Overview
7.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Microgen Key News
8 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity, Analysis
8.1 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity, 2017-2028
8.2 Tuberculosis Prevention and Treatment Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Prevention and Treatment Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Prevention and Treatment Vaccine Supply Chain Analysis
10.1 Tuberculosis Prevention and Treatment Vaccine Industry Value Chain
10.2 Tuberculosis Prevention and Treatment Vaccine Upstream Market
10.3 Tuberculosis Prevention and Treatment Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Prevention and Treatment Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Tuberculosis Prevention and Treatment Vaccine in Global Market
Table 2. Top Tuberculosis Prevention and Treatment Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Tuberculosis Prevention and Treatment Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Type
Table 9. List of Global Tier 1 Tuberculosis Prevention and Treatment Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Prevention and Treatment Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2023-2028
Table 16. By Application ? Global Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2023-2028
Table 21. By Region ? Global Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 48. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Japan BCG Lab Corporate Summary
Table 50. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 51. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Serum Institute of India Corporate Summary
Table 53. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 54. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. AJ Vaccines Corporate Summary
Table 56. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 57. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. BioFarma Corporate Summary
Table 59. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 60. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. GreenSignal Bio Pharma Corporate Summary
Table 62. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 63. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. China National Biotec Corporate Summary
Table 65. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 66. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Biomed Lublin Corporate Summary
Table 68. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 69. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Taj Pharmaceuticals Corporate Summary
Table 71. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 72. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Ataulpho de Paiva Corporate Summary
Table 74. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 75. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. IVAC Corporate Summary
Table 77. IVAC Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 78. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Queen Saovabha Mem. Inst Corporate Summary
Table 80. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 81. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Microgen Corporate Summary
Table 83. Microgen Tuberculosis Prevention and Treatment Vaccine Product Offerings
Table 84. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Tuberculosis Prevention and Treatment Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Tuberculosis Prevention and Treatment Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Tuberculosis Prevention and Treatment Vaccine Production by Region, 2017-2022 (K Units)
Table 88. Global Tuberculosis Prevention and Treatment Vaccine Production by Region, 2023-2028 (K Units)
Table 89. Tuberculosis Prevention and Treatment Vaccine Market Opportunities & Trends in Global Market
Table 90. Tuberculosis Prevention and Treatment Vaccine Market Drivers in Global Market
Table 91. Tuberculosis Prevention and Treatment Vaccine Market Restraints in Global Market
Table 92. Tuberculosis Prevention and Treatment Vaccine Raw Materials
Table 93. Tuberculosis Prevention and Treatment Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Tuberculosis Prevention and Treatment Vaccine Downstream
Table 95. Tuberculosis Prevention and Treatment Vaccine Downstream Clients in Global Market
Table 96. Tuberculosis Prevention and Treatment Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tuberculosis Prevention and Treatment Vaccine Segment by Type
Figure 2. Tuberculosis Prevention and Treatment Vaccine Segment by Application
Figure 3. Global Tuberculosis Prevention and Treatment Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Tuberculosis Prevention and Treatment Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tuberculosis Prevention and Treatment Vaccine Revenue in 2021
Figure 9. By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 19. US Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 33. China Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Tuberculosis Prevention and Treatment Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Tuberculosis Prevention and Treatment Vaccine by Region, 2021 VS 2028
Figure 50. Tuberculosis Prevention and Treatment Vaccine Industry Value Chain
Figure 51. Marketing Channels
